PegIntron (peginterferon alfa-2b; SCH 54031)

BIOLOGICAL9 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

FibrosisHepatitisHepatitis CHepatitis C, ChronicLiver Cirrhosis

Phase 3

PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370)

CompletedNCT00039871

Merck Sharp & Dohme LLCFibrosis, Hepatitis, Hepatitis C, Chronic +1

Start: 2002-05-31End: 2007-09-30Updated: 2017-04-04

Peginterferon Dose Evaluations for Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03471)

CompletedNCT00081770

Merck Sharp & Dohme LLCHepatitis C, Chronic

Start: 2004-03-31End: 2007-11-30Updated: 2017-04-04

Inhibition of Disease Progression in Hepatitis C-infected Patients With Compensated Liver Cirrhosis (P03811) (COMPLETED)

TerminatedNCT00811967

Merck Sharp & Dohme LLCHepatitis C, Chronic, Liver Cirrhosis

Start: 2003-02-28End: 2006-05-31Updated: 2017-03-13

Phase 4

Peg-Intron/Ribavirin in G 1 HCV for Non-Extended Versus 24 Week Extended Treatment After 24 Weeks (Study P04144)(COMPLETED)

CompletedNCT00202839

Merck Sharp & Dohme LLCHepatitis C, Chronic

Start: 2005-03-31End: 2008-07-31Updated: 2017-04-06

Unknown Phase

An Observational Study of Patients With Chronic Hepatitis C Undergoing Treatment With PegIntron and Rebetol in Clinical Practice in Belgium (Study P05494)(WITHDRAWN)

WithdrawnNCT00704756

Merck Sharp & Dohme LLCHepatitis C, Hepatitis C, Chronic

Start: 2009-01-31End: 2010-03-31Updated: 2014-08-11

Efficacy of PegIntron and Rebetol in Previously Untreated Patients With Chronic Hepatitis C Infected With HCV Genotype 1/4/5/6 (Study P04243)

CompletedNCT00709059

Merck Sharp & Dohme LLCHepatitis C, Chronic

Start: 2004-12-31End: 2009-12-31Updated: 2015-11-04

Safety and Efficacy of PegIntron Plus Rebetol in Patients With Chronic Hepatitis C in Japan, Excluding (1) Subjects With HCV Genotype 1 and High Viral Load, and (2) Interferon-naïve Subjects With Low Viral Load (Study P04841)(COMPLETED)

CompletedNCT00724230

Merck Sharp & Dohme LLCHepatitis C, Hepatitis C, Chronic

Start: 2006-02-28End: 2008-12-31Updated: 2015-02-03

Evaluation of Rapid Virologic Response Among HCV Patients Treated With PegIntron and Rebetol in Brazil (Study P05427)

CompletedNCT00724854

Merck Sharp & Dohme LLCHepatitis C, Hepatitis C, Chronic

Start: 2006-08-31End: 2009-09-30Updated: 2015-02-25

Compliance of HCV Genotype 1 Infected Patients Receiving PegIntron/Rebetol and a Patient Assistance Program (Study P04671)

CompletedNCT00728494

Merck Sharp & Dohme LLCHepatitis C, Hepatitis C, Chronic

Start: 2005-10-31End: 2007-12-31Updated: 2015-07-28

Related Papers

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection.

2009-07-22833 citations